Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer
Status:
Completed
Trial end date:
2020-07-20
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to validate a safe dose of atezolizumab with dose-dense
paclitaxel and carboplatin when utilized with neoadjuvant chemotherapy and interval
cytoreductive surgery followed by maintenance atezolizumab in women with advanced ovarian
cancer.